Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

[1] Jackson C(2009)Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 34-36

[2] Cunningham D(1991)Tumour marker CA 125 in patients with digestive tract malignancies Scand J Clin Lab Invest 51 265-270

[3] Oliveira J(2000)Clinical significance and prognostic Value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer Dis Markers 16 105-110

[4] Haglund C(2011)Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer Hepatogastroenterology 58 2166-2170

[5] Kuusela P(2012)Serological assessment of gastric mucosal atrophy in gastric cancer BMC Gastroenterol 12 10-105

[6] Roberts P(2012)Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500 Clin Lab 58 97-426

[7] Jalanko H(2012)The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor Clin Lab 58 419-1160

[8] Ychou M(2002)Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence Hepatogastroenterol 49 1157-9039

[9] Duffour J(2012)Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population Mol Biol Rep 39 9031-271

[10] Kramar A(2001)The prognostic significance of preoperative serum CA 19–9 in patients with resectable gastric carcinoma: comparison with CEA J Surg Oncol 76 266-245

[1] Jackson C(2009)Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 34-36

[2] Cunningham D(1991)Tumour marker CA 125 in patients with digestive tract malignancies Scand J Clin Lab Invest 51 265-270

[3] Oliveira J(2000)Clinical significance and prognostic Value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer Dis Markers 16 105-110

[4] Haglund C(2011)Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer Hepatogastroenterology 58 2166-2170

[5] Kuusela P(2012)Serological assessment of gastric mucosal atrophy in gastric cancer BMC Gastroenterol 12 10-105

[6] Roberts P(2012)Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500 Clin Lab 58 97-426

[7] Jalanko H(2012)The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor Clin Lab 58 419-1160

[8] Ychou M(2002)Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence Hepatogastroenterol 49 1157-9039

[9] Duffour J(2012)Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population Mol Biol Rep 39 9031-271

[10] Kramar A(2001)The prognostic significance of preoperative serum CA 19–9 in patients with resectable gastric carcinoma: comparison with CEA J Surg Oncol 76 266-245